Clinical Research Directory
Browse clinical research sites, groups, and studies.
First-in-Human Single and Multiple Dose of KLA578-1 for Injection
Sponsor: Sichuan Kelun Pharmaceutical Co., Ltd
Summary
The purpose of this study is to evaluate the safety and tolerability and pharmacokinetics of single and multiple doses of KLA578-1 for injection in healthy volunteers
Official title: A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of KLA578-1 for Injection in Healthy Volunteers
Key Details
Gender
All
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2025-06-05
Completion Date
2026-05-31
Last Updated
2025-08-27
Healthy Volunteers
Yes
Conditions
Interventions
KLA578-1 for injection
Intravenous injection, single dose
Etopcoxib Tablets
P.O., single dose
Locations (1)
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China